Potential biases in estimating absolute and relative case-fatality risks during outbreaks

PLoS Neglected Tropical Diseases

Volumn 9, Issue 7, 2015, Pages 1-16

  Lipsitch, Marc ^a,b   Donnelly, Christl A ^b   Fraser, Christophe ^b   Blake, Isobel M ^b   Cori, Anne ^b   Dorigatti, Ilaria ^b   Ferguson, Neil M ^b   Garske, Tini ^b   Mills, Harriet L ^b   Riley, Steven ^b   Van Kerkhove, Maria D ^b,c   Hernán, Miguel A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASE FATALITY RISK; DATA PROCESSING; DISEASE SEVERITY; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; FATALITY; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MORTALITY; REVIEW; RISK; SURVIVAL; COMMUNICABLE DISEASES; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA;

BIAS (EPIDEMIOLOGY); COMMUNICABLE DISEASES; DATA INTERPRETATION, STATISTICAL; DISEASE OUTBREAKS; HUMANS; RISK FACTORS;

EID: 84938592688     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003846     Document Type: Review

References (42)

1. Van Kerkhove MD, Asikainen T, Becker NG, Bjorge S, Desenclos JC, et al. (2010) Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med 7: e1000275.doi: 10.1371/journal.pmed.1000275 PMID: 20532237
2. US Department of Health and Human Services (2007) Interim pre-pandemic planning guidance: Community strategy for pandemic influenza mitigation in the United States—Early targeted layered use of nonpharmaceutical interventions. Department of Health and Human Services. Washington, DC.
3. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, et al. (2014) Randomised controlled trials for Ebola: practical and ethical issues. Lancet 384: 1423-1424.doi: 10.1016/S0140-6736(14)61734-7 PMID: 25390318
4. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, et al. (2014) Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis 14: 50-56.doi: 10.1016/S1473-3099(13)70304-9 PMID: 24239323
5. Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd SC (2011) Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecur Bioterror 9: 89-115.doi: 10.1089/bsp.2011.0007 PMID: 21612363
6. Yu H, Cowling BJ, Feng L, Lau EH, Liao Q, et al. (2013) Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet 382: 138-145.doi: 10.1016/S0140-6736(13)61207-6 PMID: 23803487
7. Wang TT, Parides MK, Palese P (2012) Seroevidence for H5N1 influenza infections in humans: metaanalysis. Science 335:1463.doi: 10.1126/science.1218888 PMID: 22362880
8. Van Kerkhove MD, Riley S, Lipsitch M, Guan Y, Monto AS, et al. (2012) Comment on "Seroevidence for H5N1 influenza infections in humans: meta-analysis". Science 336: 1506; author reply 1506.doi: 10.1126/science.1221434 PMID: 22723396
9. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, et al. (2003) Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361: 1761-1766. PMID: 12781533
10. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, et al. (2009) The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 6: e1000207.doi: 10.1371/journal.pmed.1000207 PMID: 19997612
11. Presanis AM, Pebody RG, Paterson BJ, Tom BD, Birrell PJ, et al. (2011) Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ 343: d5408.doi:10. 1136/bmj.d5408 PMID: 21903689
12. Baker MG, Wilson N, Huang QS, Paine S, Lopez L, et al. (2009) Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 14: pii =19319.
13. Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, et al. (2015) Under-reporting and case fatality estimates for emerging epidemics. BMJ 350: h1115.doi: 10.1136/bmj.h1115 PMID: 25779635
14. Iuliano AD, Reed C, Guh A, Desai M, Dee DL, et al. (2009) Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. Clin Infect Dis 49: 1811-1820.doi: 10.1086/649555 PMID: 19911964
15. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.doi: 10.1126/science. 1176062 PMID: 19433588
16. Lipsitch M, Lajous M, O'Hagan JJ, Cohen T, Miller JC, et al. (2009) Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico. PLoS One 4: e6895.doi: 10.1371/journal.pone.0006895 PMID: 19742302
17. Pelat C, Ferguson NM, White PJ, Reed C, Finelli L, et al. (2014) Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach. Am J Epidemiol 180: 1036-1046.doi:10. 1093/aje/kwu213 PMID: 25255809
18. Wu JT, Ho A, Ma ES, Lee CK, Chu DK, et al. (2011) Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med 8: e1001103.doi: 10.1371/journal.pmed.1001103 PMID: 21990967
19. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, et al. (2010) The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 51: 1184-1191.doi: 10.1086/656740 PMID: 20964521
20. Cauchemez S, Van Kerkhove MD, Riley S, Donnelly CA, Fraser C, et al. (2013) Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 18 18(24):pii =20503
21. Garske T, Legrand J, Donnelly CA, Ward H, Cauchemez S, et al. (2009) Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 339: b2840.doi: 10.1136/bmj.b2840 PMID: 19602714
22. WHO Ebola Response Team (2014) Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med 371: 1481-1495.doi: 10.1056/NEJMoa1411100 PMID: 25244186
23. Kucharski AJ, Edmunds WJ (2014) Case fatality rate for Ebola virus disease in west Africa. Lancet 384: 1260
24. Ghani AC, Donnelly CA, Cox DR, Griffin JT, Fraser C, et al. (2005) Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol 162: 479-486. PMID: 16076827
25. Jewell NP, Lei X, Ghani AC, Donnelly CA, Leung GM, et al. (2007) Non-parametric estimation of the case fatality ratio with competing risks data: an application to Severe Acute Respiratory Syndrome (SARS). Stat Med 26: 1982-1998. PMID: 16981181
26. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM (2009) Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 361: 112-115.doi: 10.1056/NEJMp0904380 PMID: 19474417
27. Psaty BM, Koepsell TD, Lin D, Weiss NS, Siscovick DS, et al. (1999) Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 47: 749-754
28. PMID: 10366179
29. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, et al. (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. The Lancet Respiratory Medicine 2: 395-404.doi: 10.1016/S2213-2600(14)70041-4 PMID: 24815805
30. Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, et al. (2010) Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. J Infect Dis 202: 1154-1160.doi: 10.1086/656316 PMID: 20831384
31. Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, et al. (2011) Strengthening observational evidence for antiviral effectiveness in influenza A (H5N1). J Infect Dis 204: 810-811.doi: 10.1093/infdis/ jir398 PMID: 21844308
32. Chan PK, Lee N, Zaman M, Adisasmito W, Coker R, et al. (2012) Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis 206: 1359-1366.doi: 10.1093/infdis/jis509 PMID: 22927451
33. Hernan MA, Hernandez-Diaz S, Robins JM (2004) A structural approach to selection bias. Epidemiology 15: 615-625. PMID: 15308962
34. Greenland S (1996) Basic methods for sensitivity analysis of biases. Int J Epidemiol 25: 1107-1116. PMID: 9027513
35. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, et al. (2011) Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 8: e1001053.doi: 10.1371/journal.pmed.1001053 PMID: 21750667
36. Balter S, Gupta LS, Lim S, Fu J, Perlman SE (2010) Pandemic (H1N1) 2009 surveillance for severe illness and response, New York, New York, USA, April-July 2009. Emerg Infect Dis 16: 1259-1264.doi: 10.3201/eid1608.091847 PMID: 20678320
37. Gregory CJ, Ndiaye S, Patel M, Hakizamana E, Wannemuehler K, et al. (2012) Investigation of elevated case-fatality rate in poliomyelitis outbreak in Pointe Noire, Republic of Congo, 2010. Clin Infect Dis 55: 1299-1306.doi: 10.1093/cid/cis715 PMID: 22911644
38. Mupapa K, Mukundu W, Bwaka MA, Kipasa M, De Roo A, et al. (1999) Ebola hemorrhagic fever and pregnancy. J Infect Dis 179 Suppl 1: S11-12. PMID: 9988157
39. Majeed A, Bindman AB, Weiner JP (2001) Use of risk adjustment in setting budgets and measuring performance in primary care II: advantages, disadvantages, and practicalities. BMJ 323: 607-610. PMID: 11557710
40. Joffe S (2014) Evaluating novel therapies during the Ebola epidemic. JAMA 312: 1299-1300.doi:10. 1001/jama.2014.12867 PMID: 25211645
41. Bloom B (2014) Ebola: The Teaching and Learning Moment. Harvard International Review http://hirharvardedu/archives/7500.
42. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, et al. (2009) Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 361: 2619-2627doi: 10. 1056/NEJMoa0905498 PMID: 20042753 PLOS